The smaller pharma companies I find it tough to evaluate, so many of them can potentially do well but I do not have the bandwidth to go molecule by molecule and evaluate those companies. But I think Sun Pharma is a decent business model, so we are just holding it for the long term.
Cochin Shipyard shares tumble 8% as Q2 profit falls 50% YoY despite revenue growth
Cochin Shipyard shares fell sharply on Wednesday after the company reported a nearly 50% year-on-year decline in Q2 FY27 net profit to Rs 54 crore.
November 11, 2026